Council & Sections

The AGA Institute maintains a council to address the diverse needs and specialties of its members. The AGA Institute Council is made up of elected representatives from the 13 special interest groups, or sections, within the AGA membership. The council is responsible for the AGA Institute’s education program at Digestive Disease Week® (DDW), developing educational resources and holding events in targeted areas of practice throughout the year.

 

 

We are Now Accepting Nominations

Submit your nomination(s) for the 2018-2020 section vice chairs and nominating committees. We encourage you to nominate yourself or your colleague today. The nominee and nominator must be a current member of AGA. Please login to your AGA account to submit your nomination for Vice Chair or Nominating Committee. Once you have selected your section and position, you must search for the nominee by last name. 

The following sections are accepting nominations:

  • Basic and Clinical Intestinal Disorders (BCID)
  • Clinical Practice (CP)
  • Imaging, Endoscopy & Advanced Technology (IEAT)
  • Immunology, Microbiology & Inflammatory Bowel Diseases (IMIBD)
  • Microbiome & Microbial Diseases in the Gastrointestinal Tract (MMDGT) 
  • Obesity, Metabolism & Nutrition (OMN)

Members are welcome to submit nominations (vice chair nominees must be a resident of the U.S., Mexico or Canada). The council nomination deadline is 5 p.m. on Monday, Dec. 4. If you have questions, please contact council staff.

 

DDW® 2018 Abstract Descriptors

Find out where your abstract fits best by selecting a section below. The DDW® 2018 abstract submission site opens Oct. 19.

GI Fellow-Directed QI Session

Abstracts submitted under this role are only eligible for presentation at a special session, focused on quality improvement. Only those currently enrolled in a GI fellowship program can submit abstracts to this descriptor, and the GI fellow MUST be the primary author on the abstract submission. Medical residents are not eligible to submit abstracts to this abstract descriptor category.

Basic Mechanisms of Tissue Injury, Repair and Fibrosis

Aims to feature studies on biochemistry, biophysics, and molecular cell biology of  tissue injury, repair, and development of fibrosis.

Celiac Disease and Gluten Related Disorders

Aims to include studies on the immunology and cellular/tissue  pathogenesis of celiac disease and gluten sensitivity including  human, translational, basic in vitro cell and tissue models, genetic, and in vivo animal studies. Genetic studies which involve the elucidation of the mechanism or genetic factors that contribute to immunopathogenesis of celiac disease are included in this descriptor. Also included are large population studies that address genetics, prevalence of celiac disease in adults or children, comparative studies of risk, and differences in populations or secular trends.

Cell and Molecular Biology of Intestinal Disorders 

Cell and Molecular Biology of Intestinal Disorders 

Cell Biology, Biochemistry and Integrative Physiology

Aims to feature cellular mechanisms related to basic cell biology, biochemistry and physiology in GI health and disease.

Cell Signaling in Inflammation, Injury and Mucosal Repair

Aims to feature basic cellular and molecular signaling pathways involved in intestinal inflammation, injury and repair.

Clostridium difficile Colitis: Pathogenesis, Diagnosis, Management and Therapy

Diagnosis, management and treatment of C. difficile infection (CDI). Host-microbial crosstalk in CDI susceptibility. Microbial and Biotic-based therapy for CDI. CDI pathogenesis (excluding toxin virulence mechanism).

Diarrheal Diseases, Bacterial Overgrowth, Drug Induced and Other Enteropathies

Aims to feature clinical, epidemiological and basic studies on pathogenesis of diarrheal diseases and other enteropathies including environmental enteropathy, ischemic, toxin, drug induced, allergic, autoimmune, diverticular disease. Consequences or outcomes of these illness would be also included. Also includes clinical and basic studies on novel small molecule and biologic therapeutics, and pre- and probiotics, for the intestinal disorders including diarrhea, irritable bowel, auto immune, environmental enteropathies, drug-induced, and microbial induced intestinal diseases. This descriptor excludes celiac disease, C. difficle and the chronic inflammatory bowel diseases (IBD).

Epithelial Cell Function in Inflammation

Aims to feature studies on biochemistry, biophysics, and cell biology of ion salt and water transporters of intestine.

Epithelial Ion, Water and Nutrient Absorption

Aims to feature studies on biochemistry, biophysics, and cell biology of ion, salt, water and nutrient transporters of intestine.

Epithelial Junctions and Barrier Function

Aims to feature studies on biochemistry, biophysics, and molecular cell biology of cell adhesion and junction protein complexes, of epithelial polarization and assembly into restrictive monolayers, and in epithelial repair of barrier function after injury.

Food Intolerances, Allergy, and Sensitivities

Disaccharide deficiencies, lactose, fructose or other food intolerances or sensitivities would be included and GI manifestations of food allergies. Studies that pertain to histamines or other responses to foods or dietary changes would also come under this descriptor.  The interaction between microbiome and diet, in particular, where it relates to disease or gastrointestinal function/dysfunction would also come under this descriptor.

Genetics and Intestinal Disorders

Aims to feature clinical and basic studies on mono-genetic intestinal diseases and intestinal failure.

In Vivo Models of Gastrointestinal Disorders

Aims to feature studies on intestinal disease using animal models.

Inflammation and GI Cancers

Aims to feature studies that elucidate the pathophysiology of the intestinal cancers and effect of inflammation on this process.

Intestinal Inflammation, Fibrosis and Regeneration

Aims to feature clinical  studies of intestinal injury by inflammation, radiation or hypoxia, and mechanisms of repair, fibrosis, and stricture formation.

Irritable Bowel Syndrome: Clinical

Aims to feature clinical studies on pathogenesis, diagnosis, disease outcome, treatment, psychosocial factors, disease progression of Irritable Bowel Syndrome.

Irritable Bowel Syndrome: Pathophysiology

Aims to feature basic and translational studies on pathogenesis, diagnosis, disease outcome, and disease progression of Irritable Bowel Syndrome.

Microbial Pathogens and Toxins of the Intestine and Colon

Aims to feature studies on microbial pathogenesis for enterotoxins and bacterial, viral, fungal infections of gut - excluding C. Diff toxin induced disease.

Microbial-induced Mucosal Inflammation and Innate Immunity

Aims to feature studies on molecular cell biology of innate immune epithelial responses to microbial pathogen invasion and colonization.

Organoid Models of Gastrointestinal Disorders

Aims to feature studies on intestinal disease using intestinal organoids.

Role of the Gut Microbiome in Immune and Inflammatory Diseases

Gut microbial role in inflammatory diseases of the bowel, including inflammatory bowel diseases, Celiac disease, food allergy, graft-versus-host, Dysmotility, etc.  Mediators, mechanisms, and targets of microbial pathogenesis that cause and/or contribute to these diseases.

Stem Cell Biology

Aims to feature basic molecular cell biology, genetics, and developmental biology of intestinal stem cells.

Transcriptional, Epigenetic and Genetic Regulation of GI Function and Disease

Aims to feature studies on gene expression, gene regulation, and gene suppression leading to intestinal disease, including mechanisms by alterations of chromatin structure.

Basic Mechanisms of Tissue Injury, Repair and Fibrosis

Aims to feature studies on biochemistry, biophysics, and molecular cell biology of  tissue injury, repair, and development of fibrosis.

Carcinoid and Other GI Neuroendocrine Tumors (Genetics, Epigenetics, Cell Biology and Development)

Aims to feature basic aspects of the development, cell biology and pathophysiology of GI Neuroendocrine tumors.

Cell and Molecular Biology of Intestinal Disorders 

Aims to feature cellular mechanisms related to basic cell biology, biochemistry and physiology in GI health and disease.

Cell Biology, Biochemistry and Integrative Physiology

Aims to feature cellular mechanisms related to basic cell biology, biochemistry and physiology in GI health and disease.

Cell Signaling in Inflammation, Injury and Mucosal Repair

Aims to feature basic cellular and molecular signaling pathways involved in intestinal inflammation, injury and repair.

Cellular Plasticity and Tissue Regeneration (Remodeling, Transdifferentiation, Dedifferentiation)

Aims to feature cellular alterations associated with remodeling or transformation events involved in GI injury and disease.

Chemosensing in the GI Tract

Aims to feature basic studies on the mechanism of specific cells, hormones, and receptors in sensing nutrients.

Epithelial Junctions and Barrier Function

Aims to feature studies on biochemistry, biophysics, and molecular cell biology of cell adhesion and junction protein complexes, of epithelial polarization and assembly into restrictive monolayers, and in epithelial repair of barrier function after injury.

Gastric Neoplasms: Precursor Lesions, Biology, Diagnosis and Therapy

Precursor lesions, biology, diagnosis and clinical therapeutics: research focused on precursors (i.e. intestinal metaplasia, dysplasia, MALTs), biology, diagnosis and clinical therapies directed at all types of gastric neoplasms. 

Genetics and Intestinal Disorders

Aims to feature clinical and basic studies on mono-genetic intestinal diseases and intestinal failure.

Growth Factors in Differentiation, Cell Proliferation, Morphogenesis and Apoptosis

Aims to feature studies on regulation of cell differentiation, proliferation, morphogenesis, and apoptosis in GI homeostasis and disease.

In Vivo Models of Gastrointestinal Disorders

Aims to feature studies on intestinal disease using animal models.

Intestinal Inflammation, Fibrosis and Regeneration

Aims to feature clinical  studies of intestinal injury by inflammation, radiation or hypoxia, and mechanisms of repair, fibrosis, and stricture formation.

Molecular Mechanisms of Growth and Development of the GI Tract, Liver and Pancreas

Basic cellular mechanisms driving the establishment, development, and function of the digestive organs. Pathways driving cellular differentiation and organ maturation.

Organoid Models of Gastrointestinal Disorders

Aims to feature studies on intestinal disease using intestinal organoids.

Receptor Signaling and Enteric Neuroscience

Aims to feature studies in pathways triggered by gastrointestinal hormones and neuropeptide receptors in GI health and disease.

Signaling Pathways Regulating Gastrointestinal Motility, Secretion and Absorption

Aims to feature basic studies on the identification of pathways involved in GI motility, secretion, and absorption in health and disease.  

Stem Cell Biology

Aims to feature basic molecular cell biology, genetics, and developmental biology of intestinal stem cells.

Tissue Engineering and Regenerative Medicine 

Cutting-edge techniques for refining, growing, and expanding engineered GI tract, liver, and pancreas tissues for replacement or augmentation of compromised organs in patients.

Transcriptional, Epigenetic and Genetic Regulation of GI Function and Disease

Aims to feature studies on gene expression, gene regulation, and gene suppression leading to intestinal disease, including mechanisms by alterations of chromatin structure.

Epidemiology

Evaluates abstracts using epidemiologic methods that do not easily fit into other descriptors.

Health Care Delivery and Policy (Practice Management, Reimbursement, Access to Care, Policy)

Evaluates abstracts pertaining to business issues of practice (either community or academic), government or insurer policies including analyses of their effects, and access to care. This descriptor is not intended for cost-effectiveness analyses, process improvement, or performance metrics.

Health Disparities and Global Health

Evaluates abstracts regarding disparities in health outcomes based on race or socioeconomic status. Also evaluates studies specific to healthcare in developing countries, including epidemiology, delivery of healthcare, and outcomes. Authors might consider instead submitting abstracts to other descriptors specific to diseases studied. 

Health Economics (Cost of Illness, Cost-Effectiveness, and Health Economic Models)

Evaluates studies of computer simulations or empirically observed cost data. Not intended for abstracts regarding practice management issues or reimbursement.

Medical Education and Training

Evaluates studies where the unit of observation is the provider or trainee, including observational studies and interventions. Not intended for patient case reports or clinical pearls.

Patient Reported Outcomes: IBD, GERD, Functional Disorders, Other

Evaluates abstracts regarding development or validation of Patient Reported Outcomes (PROs) instruments, including those regarding quality of life. Also evaluates abstracts where the primary outcome is Patient Reported Outcomes, particularly if the abstract does not easily fit in another descriptor.

Performance Metrics, Process Improvement, and Implementation Science

Evaluates abstracts pertaining to, for instance, methodologic advances in measuring quality of care, studies identifying key processes to be targeted for improving quality of care, and observational or experimental studies with a primary outcome being quality of care. Also evaluates abstracts regarding studies evaluating implementation of best practices or quality assurance programs in clinical practice. The descriptor is not intended for abstracts pertaining to quality of life, endoscopic innovations, or animal studies.

Population Health Screening: Colorectal Cancer, Esophageal Cancer, Hepatocellular Carcinoma, Other Screening

Evaluates abstracts pertaining to screening or surveillance in populations.  For instance, screening or surveillance for cancers of the colon, esophagus, liver, or pancreas.  Additionally includes population health screening for other health outcomes, such as celiac disease, H. pylori, etc.

Systematic Reviews and Meta-Analysis

Evaluates abstracts using systematic review and meta-analyses that do not fit easily into other descriptors.

Barrett's Esophagus: Diagnosis, Management and Surveillance

Evaluates abstracts related to diagnosis, management and surveillance of patients with Barrett’s esophagus. It is not intended for abstracts relating to GERD or EoE or esophageal motility disorders.

Eosinophilic Esophagitis: Clinical

Evaluates clinical abstracts related to the diagnosis, testing or management of patients with eosinophilic esophagitis. It is intended for the clinical fields, but it is not intended for abstracts relating to GERD, Barrett’s esophagus or esophageal motility disorders.  

Eosinophilic Esophagitis: Translational or Basic

Evaluates basic science or translational abstracts related to disease pathogenesis and treatment. It is not intended for abstracts relating to GERD, Barrett’s esophagus or esophageal motility disorders.  

Esophageal Motility and Dysmotility

Evaluates abstracts pertaining to dysphagia, high resolution manometry, lower esophageal sphincter (LES), esophagogastric junction (EGJ), FLIP/EndoFLIP, Achalasia, GERD, Esophageal sensory function, chest pain, POEM, fundoplication, impedance, functional heartburn, functional chest pain, reflux hypersensitivity, supragastric belching.

Functional Dyspepsia, Nausea and Vomiting

Evaluates abstracts pertaining to abdominal pain, nausea, functional dyspepsia, non ulcer dyspepsia, psychological distress, pathophysiologic distress, vomiting, rumination, cyclical vomiting syndrome, cannabis hyperemesis syndrome, epigastric pain syndrome, postprandial distress syndrome.

Gastric Neoplasms: Precursor Lesions, Biology, Diagnosis and Therapy

Precursor lesions, biology, diagnosis and clinical therapeutics: research focused on precursors (i.e. intestinal metaplasia, dysplasia, MALTs), biology, diagnosis and clinical therapies directed at all types of gastric neoplasms. 

GERD/Barrett's: Pathogenesis

Evaluates clinical or translational abstracts about pathogenesis of GERD and Barrett’s esophagus. This descriptor is not intended for pathogenesis of other esophageal conditions such as EoE or esophageal carcinoma.  

GERD: Complications and Extra-Esophageal Presentations

Evaluates abstracts related to complications of GERD such as esophageal strictures as well as extraesophageal presentations such as asthma, laryngitis, cough, chest pain or post lung transplant rejection. It is not intended for abstracts relating to Barrett’s esophagus or EoE or esophageal motility disorders.

GERD: Diagnostic Testing

Evaluates abstracts related to diagnostic testing in GERD. It is not intended for abstracts relating to Barrett’s esophagus or EoE or esophageal motility disorders.

GERD: Medical, Surgical and Endoscopic Therapies

Evaluates abstracts related to medical, surgical, and endoscopic therapies in the management of GERD and its related complications. It is not intended for abstracts related to GERD pathogenesis, complications and extra-esophageal presentations, and diagnostic testing.

Helicobacter pylori: Epidemiology, Diagnosis and Outcomes

Evaluates abstracts related to epidemiology, diagnosis and, outcomes of H. pylori infection. It is not intended for abstracts related to H. pylori host response, pathogenic mechanisms, treatment, or antimicrobial resistance.

Helicobacter pylori: Host Response and Pathogenesis

Evaluates abstracts related to host response induced by H. pylori infection and understanding mechanisms of disease pathogenesis during H. pylori infection. It is not intended for abstracts related to H. pylori epidemiology, treatment, diagnosis, or outcomes.   

Helicobacter pylori: Treatment and Antimicrobial Resistance

Evaluates abstracts related to H. pylori treatment and antimicrobial resistance. It is not intended for abstracts related to H. pylori host response, pathogenic mechanisms, epidemiology, or outcomes.

Molecular Mechanisms of Growth and Development of the GI Tract, Liver and Pancreas

Basic cellular mechanisms driving the establishment, development, and function of the digestive organs. Pathways driving cellular differentiation and organ maturation.

Mucosal Defense, Secretion, Injury, Repair and Healing

Evaluates abstracts related to mechanisms of upper GI mucosal defense, secretion, injury, repair and healing. It is not intended for abstracts related to H. pylori host response or pathogenic mechanisms.

Peptic Ulcer Disease and Non-Variceal UGI Bleeding

Evaluates abstracts related to NSAIDs and peptic ulcer diseases and non-variceal UGI bleeding. It is not intended for abstracts related to H. pylori induced diseases or mechanisms of mucosal injury and repair.

Biomarkers for Detection, Treatment and Prognosis of GI Cancers

Research focused on biomarkers used for the detection, treatment, and/or prognosis of GI cancers. Biomarker analysis can be on tissues or serum. Biomarkers can include DNA, RNAs, miRNAs, or proteins. Research can include both clinical and preclinical models of GI cancer.

Cancer Prevention and Chemoprevention

Research focused on cancer prevention or chemoprevention of GI cancers. Research can include both clinical and preclinical models of GI cancer. Innovative cancer prevention techniques in addition to pharmacologic strategies are included in this descriptor.

Cancer Stem Cells and Circulating Tumor Cells

Research identifying cancer stem cells and circulating tumor cells in cell culture, animal models or human subjects. This includes mechanistic studies on their origin, survival, migration and metastasis. It also includes preclinical diagnostic and therapeutic studies.

Canceromics: Cancer Genomics, Epigenomics, Metabolomics, Proteomics and Systems Biology

Cancer genomics, epigenomics, metabolomics, proteomics, and systems biology: research focused on genomics (DNA), epigenomics (i.e. methylation, histone modifications), proteomics (protein), and systems biology (i.e. metabolic or cell signaling networks) aimed at the complex interactions in cancer biology. Research can include both clinical and preclinical models of GI cancer.

Carcinoid and Neuroendocrine Neoplasms: Biology, Diagnosis and Clinical Therapeutics

Biology, Diagnosis and Clinical Therapeutics: research focused on the, biology, diagnosis and clinical therapies directed at carcinoid and neuroendocrine neoplasms.

Carcinoid and Other GI Neuroendocrine Tumors (Genetics, Epigenetics, Cell Biology and Development)

Aims to feature basic aspects of the development, cell biology and pathophysiology of GI Neuroendocrine tumors.

Colon Cancer Screening

Research focused on colon cancer screening using clinical and/or molecular techniques, outcomes of screening, innovative techniques for screening. Research can include both clinical and preclinical models of colon cancer.

Epidemiology

Evaluates abstracts using epidemiologic methods that do not easily fit into other descriptors.

Esophageal and Junctional Neoplasms: Precursor Lesions, Biology, Diagnosis and Clinical Therapeutics

Precursor Lesions, Biology, Diagnosis and Clinical Therapeutics: research focused on precursors (i.e. Barrett’s metaplasia, dysplasia), biology, diagnosis and clinical therapies directed at both esophageal squamous and adenocarcinomas.

Familial Cancer Syndromes and Cancer Genetics

Research focused on inherited risk factors for cancer, including diagnostics and therapeutics. This includes gene mutations, epigenetic and imprinted mechanisms, and includes any and all inherited syndromes increasing GI cancer risk. It also includes diagnostic and screening approaches, as well as preclinical chemoprevention and therapeutic studies.

Gastric Neoplasms: Precursor Lesions, Biology, Diagnosis and Therapy

Precursor lesions, biology, diagnosis and clinical therapeutics: research focused on precursors (i.e. intestinal metaplasia, dysplasia, MALTs), biology, diagnosis and clinical therapies directed at all types of gastric neoplasms. 

GI Cancer Research Models: Organoids, Engineered Cell and Tissue Platforms, and Animal Models

Organoids, Engineered Cell and Tissue Platforms, and Animal Models: Research in which GI cancer models are the focus, including new transgenic animal models for GI cancers as well as crosses or other modifications that significantly alter the cancer phenotype and provide insight into cancer pathogenesis. It also includes any primary cell culture of tissues from human, murine, or other organisms. Also includes approaches to genetically modify cells including CRISPR and other techniques.

Growth Factors in Differentiation, Cell Proliferation, Morphogenesis and Apoptosis

Aims to feature studies on regulation of cell differentiation, proliferation, morphogenesis, and apoptosis in GI homeostasis and disease.

Inflammation and GI Cancers

Aims to feature studies that elucidate the pathophysiology of the intestinal cancers and effect of inflammation on this process.

Liver and Biliary Carcinoma: Management, Etiology, Diagnosis and Natural History

Precursor Lesions, Biology, Diagnosis and Clinical Therapeutics: research focused on precursors (i.e. dysplasia), biology, diagnosis and clinical therapies directed at liver and biliary cancers. 

Metabolism, Obesity, Microbiome, and Nutrition in GI Cancer Pathogenesis

Research focused on the roles played by metabolism, obesity, the microbiome, and nutrition in the initiation and progression of cancers of the gastrointestinal tract. This includes studies exploring these processes promoting carcinogenesis separately or as interacting and inter-related pathways, as well as in-depth studies of molecular pathways. It also includes mechanistic or population studies exploring novel cancer prevention and treatment strategies which modulate a subject’s metabolism, obesity, microbiome, and nutritional state, including the use of nutritional supplements.

Microbiome and Cancer

Role of the gut microbiome in the initiation and progression of cancers of the gastrointestinal tract and other organ systems. Also the role of gut microbes in cancer prevention and modulation of tumor immunology and metabolism. Mechanisms and mediators that are involved in these processes.

Molecular Mechanisms and Pathways in Carcinogenesis and Metastasis: Bench to Bedside

Research focused on signaling pathways, molecules, receptors, and downstream effectors that regulate key processes in cancer cells, including signaling that drives carcinogenesis, cancer cell survival, and metastasis, as well as other cellular processes.

Pancreatic Cancer: Risk Factors, Biology, Diagnosis and Clinical Therapeutics

Both clinical and basic science aspects specially with biomarkers can fit in here. Almost all adenocarcinoma abstracts should fit this descriptor although there may be some overlap for cystic neoplasms and cancer with the descriptor PCN, IPMN and neuroendocrine tumors.

Population Health Screening: Colorectal Cancer, Esophageal Cancer, Hepatocellular Carcinoma, Other Screening

Evaluates abstracts pertaining to screening or surveillance in populations.  For instance, screening or surveillance for cancers of the colon, esophagus, liver, or pancreas.  Additionally includes population health screening for other health outcomes, such as celiac disease, H. pylori, etc.

Systematic Reviews and Meta-Analysis

Evaluates abstracts using systematic review and meta-analyses that do not fit easily into other descriptors.

Translational and Targeted Therapies for GI Cancers

Research focused on GI cancer therapies, including development of novel targets, innovative reagents and treatments. Includes high through-put screens, research into delivery vehicles including nanoparticles, and includes chemotherapies, biological therapies, irradiation and other treatment modalities.

Tumor Cell Biology, Immunology, and Microenvironment

Research focused on cancer cell biology, including mechanisms of cell proliferation, survival, migration, morphology, metabolism, and gene/protein expression, with a focus on molecular mechanisms responsible for the cancer cell phenotype. This also includes studies of all aspects of the local tissue environment (non-tumor cells, extracellular matrix) influencing cancer cell biology and survival. 

Biotics in Health and Disease

Use of prebiotics, probiotics, postbiotics and synbiotics (biotics) in the treatment and prevention of GI and extraintestinal disease. Biotic functions, mechanisms of action and interactions with the endogenous microbiome and host.  Bioengineering new biotic functions.  Biotic clinical and regulatory considerations.   

Clinical Pediatric Gastroenterology: Other

Aims to feature clinical studies on a variety of pediatric gastrointestinal disorders that do not include inflammatory bowel disease, liver, biliary, functional or motility disorders. This can include, but is not limited to, celiac disease, pancreatic conditions, enteropathies, eosinophilic disorders and malabsorption.

Development and Aging of GI Tract Function

 

Development of the Enteric Nervous System 

The molecular and cellular mechanisms by which the enteric nervous system develops and matures, and the physiological and pathological consequences when these processes fail.

Food Intolerances, Allergy, and Sensitivities

Disaccharide deficiencies, lactose, fructose or other food intolerances or sensitivities would be included and GI manifestations of food allergies. Studies that pertain to histamines or other responses to foods or dietary changes would also come under this descriptor.  The interaction between microbiome and diet, in particular, where it relates to disease or gastrointestinal function/dysfunction would also come under this descriptor.

Genetics and Intestinal Disorders

Aims to feature clinical and basic studies on mono-genetic intestinal diseases and intestinal failure.

In Vivo Models of Gastrointestinal Disorders

Aims to feature studies on intestinal disease using animal models.

Molecular Mechanisms of Growth and Development of the GI Tract, Liver and Pancreas

Basic cellular mechanisms driving the establishment, development, and function of the digestive organs. Pathways driving cellular differentiation and organ maturation.

Organoid Models of Gastrointestinal Disorders

Aims to feature studies on intestinal disease using intestinal organoids.

Pediatric Functional and Motility Disorders

Aims to feature clinical and translational studies of functional and motility disorders in pediatric populations.

Pediatric IBD: Clinical and Translational Studies

Aims to feature clinical and translational studies of inflammatory bowel diseases in pediatric populations.

Pediatric Liver and Biliary Diseases

Aims to feature clinical and translational studies related to liver and biliary diseases in pediatric populations.

Pediatric Nutrition and Obesity

Studies of the metabolic abnormalities and morbidities associated with obesity in children, including metabolic syndrome and NAFLD, and their relationship to nutrition and genetics. Also, studies of approaches to the treatment of pediatric obesity, including the roles of nutritional intervention, lifestyle changes, pharmacotherapy and bariatric surgery.

Stem Cell Biology

Aims to feature basic molecular cell biology, genetics, and developmental biology of intestinal stem cells.

The Gut Microbiome in Pediatric Development and Disease

The roles and mechanisms of gut microbes in influencing host metabolism, immunity, growth and development, etc. during the neonatal, childhood, and adolescent periods. The impact of dysbiosis on disease risk and outcomes later in life.  Host factors that determine the compositional and functional development of gut microbiomes in pediatric populations. 

Tissue Engineering and Regenerative Medicine 

Cutting-edge techniques for refining, growing, and expanding engineered GI tract, liver, and pancreas tissues for replacement or augmentation of compromised organs in patients.

Cutting-edge techniques for refining, growing, and expanding engineered GI tract, liver, and pancreas tissues for replacement or augmentation of compromised organs in patients.

Aims to feature studies on gene expression, gene regulation, and gene suppression leading to intestinal disease, including mechanisms by alterations of chromatin structure.

Confocal Endomicroscopy and Other Optical Sectioning Techniques

Evaluates abstracts pertaining to use of an microscope to produce real-time images within the human body or animal that correspond to histology. This may include confocal endomicroscopy or volumetric laser endomicroscopy.

Diagnostic and Therapeutic Applications

Evaluates abstracts about the use of novel imaging or technology for the diagnosis or therapy of gastrointestinal, liver or pancreatobiliary disorders.

Enhanced Endoscopic Imaging Including Molecular Imaging; Spectroscopy and Fluorescence Imaging; and Optical Coherence Tomography

Evaluates abstracts that utilize enhanced endoscopic imaging, including molecular imaging; spectroscopy, fluorescence imaging and optical coherence tomography.

Epithelial Cell Function in Inflammation

Aims to feature studies on biochemistry, biophysics, and cell biology of ion salt and water transporters of intestine.

Imaging and Therapeutic Intervention in Obesity and Metabolic Disease

Evaluates abstracts submitted to study the use of image modalities or applications of new or existing technology or therapeutic techniques for treatment of obesity or metabolic disorders such as diabetes.

Imaging of the GI Tract

Evaluates abstracts that studies the role of imaging of any organ of the gastrointestinal tract, namely the esophagus, stomach, small bowel, colon, pancreas, bile duct, liver or gallbladder.

Imaging Techniques Including Comparative Studies and Efficacy

Evaluates research that compares outcomes of one or more imaging or technology devices in animal models or humans.

Novel/Experimental Endoscopy

Evaluates research in animals or humans that studies the application of novel endoscopic tools or equipment, the role of endoscopy to treat a novel indication or application of a new technique.

Animal Models: Pre-Clinical Treatment of Intestinal Inflammation

Studies in animal models that assess potential therapeutic pathways and interventions for IBD.

IBD: Adverse Events Related to Therapy

Evaluates studies related to complications of medical, surgical and alternative therapies for IBD.

IBD: Comparative Effectiveness Studies

Studies providing a direct comparison of existing health care interventions for IBD to determine best approaches for patients and comparing benefits and harms.

IBD: Controlled Clinical Trials in Humans

Randomized and/or placebo controlled trials of interventions for IBD.

IBD: Cytokines, Signaling and Receptors

Basic or translational studies on cytokines, signaling and receptors and their role in intestinal inflammation as it relates to IBD.

IBD: Diagnostics in IBD

Evaluates tests of blood, stool, imaging, endoscopy or other novel tests for determining presence (diagnosis) of IBD or classification of IBD.

IBD: Disease Activity Assessment

Evaluates tests of blood, stool, imaging, endoscopy, or other novel tests and scoring systems for determining disease severity of IBD including presence of mucosal healing.

IBD: Disease Complications

Studies evaluating adverse outcomes of IBD; Not related to medical or surgical therapy.

IBD: Epidemiology

Studies of the incidence, prevalence and risk factors for IBD.

IBD: Genomics and Gene Function

Basic or translational studies related to genetics, genomics, gene function and other -omics studies and their relationship to basic IBD mechanism's or clinical outcomes.

IBD: Innate and Adaptive Lymphoid Activation and Regulation

Basic or translational studies of innate and adaptive lymphoid activation and regulation related to IBD.

IBD: Microbiome

 

IBD: Natural History and Outcomes

Studies focusing on the evolution or changing quality of IBD disease behavior or phenotype over time.

IBD: Practice Management/Quality of Care/Quality Assurance

Evaluates access and effectiveness. Do IBD patients get the care they need, and is the care effective when they get it?

IBD: Quality of Life/Psychosocial Care

Evaluates general well-being of individuals and societies with IBD and relationship of QOL with health (physical and mental) and wellness

IBD: Therapeutic Monitoring

Evaluates the use and effectiveness of drug levels in IBD.

IBD: Uncontrolled Therapeutic Observations in Humans Biologic

Studies of interesting and relevant findings in individuals receiving therapy (medical or surgical) for IBD, retrospective case series, new therapies, etc.

IBD: Uncontrolled Therapeutic Observations in Humans Non-Biologic

 

Intestinal Inflammation, Fibrosis and Regeneration

Aims to feature clinical  studies of intestinal injury by inflammation, radiation or hypoxia, and mechanisms of repair, fibrosis, and stricture formation.

Microbial-Based Therapy

Use of microbiome-based therapy (fecal transplantation and defined microbial communities) in the treatment and prevention of GI and extraintestinal disease. Microbiome-based therapy and functions, mechanisms of action, interactions with endogenous microbiota and host. Bioengineering of new microbiome-based therapy and functions: clinical and regulatory considerations.

Microbial-induced Mucosal Inflammation and Innate Immunity

Aims to feature studies on molecular cell biology of innate immune epithelial responses to microbial pathogen invasion and colonization.

Mucosal Innate Immune Function and Innate Host Defense

Basic and translational studies on mucosal innate immune function and innate host defense - human or animal studies.

Pediatric IBD: Clinical and Translational Studies

Aims to feature clinical and translational studies of inflammatory bowel diseases in pediatric populations.

Role of the Gut Microbiome in Immune and Inflammatory Diseases

Gut microbial role in inflammatory diseases of the bowel, including inflammatory bowel diseases, Celiac disease, food allergy, graft-versus-host, Dysmotility, etc.  Mediators, mechanisms, and targets of microbial pathogenesis that cause and/or contribute to these diseases.

Alcoholic Fatty Liver Diseases

Research abstracts on all aspects of basic, translational, and clinical sciences related to alcoholic liver disease.

Clinical Biliary Tract Disorders, Stone Diseases and Stone Pathogenesis

Research abstracts on all aspects of basic, translational, and clinical sciences related to biliary tract disease.

Clinical Hepatitis: Etiology, Diagnosis and Natural History

Clinical research abstracts in viral hepatitis including epidemiology, natural history, etiology, diagnosis, and biomarkers, and health disparities.

Clinical Hepatitis: Prevention and Treatment

Clinical research abstracts in viral hepatitis including  prevention, vaccination, public health, pharmacological treatments, surgery, liver transplantation, and health disparities.

Complications of Cirrhosis and Portal Hypertension

Research abstracts on all aspects of basic, translational, and clinical sciences related to cirrhosis and complications of portal hypertension.

Extraintestinal Interactions of the Gut Microbiome

Considers the functional cross-talk between the gut microbiota and extraintestinal organs (excluding nervous system). Microbiota-based mechanisms and therapy in extra-intestinal disease pathogenesis. Organs affected include: liver, pancreas, kidney, lymphoid, cardiovascular, bone, respiratory and mucosal systems.  Also, consider extraintestinal control of microbiota composition and function.

Hepatic Fibrosis, Diagnosis and Treatment

Research abstracts on all aspects of basic, translational, and clinical sciences related to the diagnosis and treatment of hepatic fibrosis.

Liver and Biliary Carcinoma: Management, Etiology, Diagnosis and Natural History

Precursor Lesions, Biology, Diagnosis and Clinical Therapeutics: research focused on precursors (i.e. dysplasia), biology, diagnosis and clinical therapies directed at liver and biliary cancers.

Metabolic and Genetic Liver Disease

Research abstracts on all aspects of basic, translational, and clinical sciences related to metabolic and genetic liver diseases.

Molecular Mechanisms of Growth and Development of the GI Tract, Liver and Pancreas

Basic cellular mechanisms driving the establishment, development, and function of the digestive organs. Pathways driving cellular differentiation and organ maturation.

Non-Alcoholic Fatty Liver Diseases and NASH

Research abstracts on all aspects of basic, translational, and clinical sciences related to non-alcoholic fatty liver disease and NASH.

Pharmacoeconomics and Cost-Effectiveness Analysis of Liver Disease

Clinical research abstracts including epidemiology, health services research, health economics, decision analysis,  comparative effectiveness analysis, role of diagnostic testing, and implications for clinical practice.

Biotics in Health and Disease

Use of prebiotics, probiotics, postbiotics and synbiotics (biotics) in the treatment and prevention of GI and extraintestinal disease. Biotic functions, mechanisms of action and interactions with the endogenous microbiome and host.  Bioengineering new biotic functions.  Biotic clinical and regulatory considerations.

Clostridium difficile Colitis: Pathogenesis, Diagnosis, Management and Therapy

Diagnosis, management and treatment of C. difficile infection (CDI). Host-microbial crosstalk in CDI susceptibility. Microbial and Biotic-based therapy for CDI. CDI pathogenesis (excluding toxin virulence mechanism).

Diet and the Gut Microbiome

Dietary impact on the composition and function of the gut microbiome and how their effects alter host-microbe interactions in conditions of health and disease. Microbial strains, mechanisms, mediators, and pathways that are involved in dietary effects on host and microbe. The role and actions of specific dietary components in affecting the gut microbiome. Clinical trials and studies of dietary intervention to reshape the gut microbiome as interventions for diseases and/or maintenance of health.

Extraintestinal Interactions of the Gut Microbiome

Considers the functional cross-talk between the gut microbiota and extraintestinal organs (excluding nervous system). Microbiota-based mechanisms and therapy in extra-intestinal disease pathogenesis. Organs affected include: liver, pancreas, kidney, lymphoid, cardiovascular, bone, respiratory and mucosal systems.  Also, consider extraintestinal control of microbiota composition and function.

Intestinal Inflammation, Fibrosis and Regeneration

Aims to feature clinical  studies of intestinal injury by inflammation, radiation or hypoxia, and mechanisms of repair, fibrosis, and stricture formation.

Microbial Dysbiosis: Causes and Consequences

Compositional and functional alterations of the gastrointestinal microbiome that disturb host function, physiology, and cause or contribute to the risk/development/natural history of diseases that affect the GI tract and other organ systems. Environmental, dietary, microbial, and host factors that result in the development of gut dysbiosis.

Microbial Pathogens and Toxins of the Intestine and Colon

Aims to feature studies on microbial pathogenesis for enterotoxins and bacterial, viral, fungal infections of gut - excluding C. Diff toxin induced disease.

Microbial Regulation of Host Metabolic and Energy Homeostasis

The role and mediators gut microbial regulation of host energy balance, digestion and absorption, circadian rhythm, and other metabolic targets and organs. Microbial role in obesity, metabolic syndrome, Type 2 diabetes, non-alcoholic liver disease, cardio-vascular complications, malabsorption, and malnutrition. Impact of these diseases on gut microbial function and composition.

Microbial-Based Therapy

Use of microbiome-based therapy (fecal transplantation and defined microbial communities) in the treatment and prevention of GI and extraintestinal disease. Microbiome-based therapy and functions, mechanisms of action, interactions with endogenous microbiota and host. Bioengineering of new microbiome-based therapy and functions: clinical and regulatory considerations.

Microbial-induced Mucosal Inflammation and Innate Immunity

Aims to feature studies on molecular cell biology of innate immune epithelial responses to microbial pathogen invasion and colonization.

Microbiome and Cancer

Role of the gut microbiome in the initiation and progression of cancers of the gastrointestinal tract and other organ systems. Also the role of gut microbes in cancer prevention and modulation of tumor immunology and metabolism. Mechanisms and mediators that are involved in these processes.

Microbiome and Infectious Diseases

Pathogens and pathogenic virulence mechanisms that affect the gut microbiome and cause infectious diseases (viral, fungal, parasitic, bacterial, excluding C. difficile infection). Alternations in genomics and function of commensal microbes that lead to negative, disease-causing consequences. Perturbations or aberrant host functions that lead to altered gut microbial function that can promote infectious diseases.

New Technologies and Analytic Tools for the Study of the Gut Microbiome

Advances in multi-omics technologies, cultivation approaches, animal/tissue/cell models, microbial genetic engineering, computational modeling and simulation, and bioinformatics tools/platforms that provide new insights and opportunities for the study of the gastrointestinal microbiome.

Non-Alcoholic Fatty Liver Diseases and NASH

Research abstracts on all aspects of basic, translational, and clinical sciences related to non-alcoholic fatty liver disease and NASH.

Role of the Gut Microbiome in Immune and Inflammatory Diseases

Gut microbial role in inflammatory diseases of the bowel, including inflammatory bowel diseases, Celiac disease, food allergy, graft-versus-host, Dysmotility, etc.  Mediators, mechanisms, and targets of microbial pathogenesis that cause and/or contribute to these diseases.

Sensory Neurobiology Including Visceral Nociception/Pain and Neuroimmunology (Neurogenic Inflammation and Interactions with the Microbiome)

Evaluates abstracts pertaining to basic visceral pain, microbiome, neuromediators, neurotransmitters, neurogenic Inflammation, pain, viscero-visceral cross talk, gut microbiota, visceral hypersensitivity.

The Gastrointestinal Microbiome: Determinants and Dynamics of Structure and Function

The mechanisms and mediators of dietary, environmental, host, and intracommunity microbial factors that shape the regional gastrointestinal microbiomes. The interplay of all these factors in determining microbial assemblage of individuals in both physiological and pathophysiological conditions.

The Gut Microbiome in Pediatric Development and Disease

The roles and mechanisms of gut microbes in influencing host metabolism, immunity, growth and development, etc. during the neonatal, childhood, and adolescent periods. The impact of dysbiosis on disease risk and outcomes later in life.  Host factors that determine the compositional and functional development of gut microbiomes in pediatric populations.

The Microbiome in Pancreatitis, Pancreatic Malabsorption and Pancreatic Tumorigenesis

Considers emerging work in microbiome in pancreatic diseases including effects of pancreatic diseases on the microbiome, as well as the effects of the microbiome on pancreatic diseases.

The Microbiome-Gut-Brain Axis in Health and Disease

Functional cross-talk between the gut microbiota and the host nervous system (central and peripheral). Microbial neuroendocrinology in GI and extraintestinal disease. Microbial and biotic-based therapy: mechanisms of action and regulation of neuropathy, behavioral and autism spectrum disorders, functional bowel disease and abdominal pain, allergy, inflammatory and infectious disease. Nervous system control of microbiota composition and function.

Viral, Eukaryote, and Prokaryote Members of the Gut Microbiome

Defining members of non-bacterial kingdoms of the gastrointestinal microbiome – their relative importance, function, and interactions with other members of the microbial community and host.

Anorectal Dysmotility (Including Fecal Incontinence, Dyssynergia and Pelvic Floor Disorders)

Evaluates abstracts pertaining to high resolution anorectal manometry, disordered/dyssynergic defecation, fecal incontinence, anal sphincter dysfunction, rectal hyposensitivity and hypersensitivity, biofeedback therapy, anorectal surgery, rectocele, prolapse, barostat, anal Endoflip.

Brain-Gut Axis (Including Neuroimaging, Vagal Pathways and Neurobiology of Satiety, Obesity and Metabolic Disorders)

Evaluates abstracts pertaining to cortical evoked potentials, obesity, satiety, metabolomics, neural pathways, vagus nerve stimulation, vagal afferent neurons, ascending and descending brain-gut pathways, brain imaging and functional GI disorders.

Constipation and Other Functional Colonic Syndromes

Evaluates abstracts pertaining to functional constipation, slow transit constipation, IBS with constipation, diverticular disease, microscopic colitis, opioid-induced, opioid therapy, colon motility, colon sensory function, treatments.

Development of the Enteric Nervous System

The molecular and cellular mechanisms by which the enteric nervous system develops and matures, and the physiological and pathological consequences when these processes fail.

Diarrheal Diseases, Bacterial Overgrowth, Drug Induced and Other Enteropathies

Aims to feature clinical, epidemiological and basic studies on pathogenesis of diarrheal diseases and other enteropathies including environmental enteropathy, ischemic, toxin, drug induced, allergic, autoimmune, diverticular disease. Consequences or outcomes of these illness would be also included. Also includes clinical and basic studies on novel small molecule and biologic therapeutics, and pre- and probiotics, for the intestinal disorders including diarrhea, irritable bowel, auto immune, environmental enteropathies, drug-induced, and microbial induced intestinal diseases. This descriptor excludes celiac disease, C. difficle and the chronic inflammatory bowel diseases (IBD).

Enteric Neurobiology: Cell and Molecular Biology (Including Neurons, Glia, ICC, Smooth Muscle and Stem Cells)

Evaluates abstracts pertaining to enteric Glia, ICC, cajal populations, enertic neurons, cross talk.

Enteric Neuromuscular Biology: Pharmacology

Evaluates abstracts pertaining to high resolution mapping, enterochromaffin cells (EC), gastric electrical stimulation/electrical activity.

Epithelial Junctions and Barrier Function

Aims to feature studies on biochemistry, biophysics, and molecular cell biology of cell adhesion and junction protein complexes, of epithelial polarization and assembly into restrictive monolayers, and in epithelial repair of barrier function after injury.

Esophageal Motility and Dysmotility

Evaluates abstracts pertaining to dysphagia, high resolution manometry, lower esophageal sphincter (LES), esophagogastric junction (EGJ), FLIP/EndoFLIP, Achalasia, GERD, Esophageal sensory function, chest pain, POEM, fundoplication, impedance, functional heartburn, functional chest pain, reflux hypersensitivity, supragastric belching.

Functional Dyspepsia, Nausea and Vomiting

Evaluates abstracts pertaining to abdominal pain, nausea, functional dyspepsia, non ulcer dyspepsia, psychological distress, pathophysiologic distress, vomiting, rumination, cyclical vomiting syndrome, cannabis hyperemesis syndrome, epigastric pain syndrome, postprandial distress syndrome.

Gastroparesis and Small Intestinal Dysmotility

Evaluates abstracts pertaining to diabetes/diabetic, gastric electrical stimulator, gastric slow wave, gastric emptying, wireless motility capsule, scintigraphy, antroduodenal motility, pathophysiology, treatment, gastric electrical stimulation, electrogastrography, obesity, treatments.

Irritable Bowel Syndrome: Clinical

Aims to feature clinical studies on pathogenesis, diagnosis, disease outcome, treatment, psychosocial factors, disease progression of Irritable Bowel Syndrome.

Irritable Bowel Syndrome: Pathophysiology

Aims to feature basic and translational studies on pathogenesis, diagnosis, disease outcome, and disease progression of Irritable Bowel Syndrome.

Oropharyngeal Dysmotility

Evaluates abstracts pertaining to oropharyngeal dysphagia, esophageal dysphagia, upper esophageal sphincter, crico-pharyngeal, hyo-laryngeal, stroke.

Pediatric Functional and Motility Disorders

Aims to feature clinical and translational studies of functional and motility disorders in pediatric populations.

Sensory Neurobiology Including Visceral Nociception/Pain and Neuroimmunology (Neurogenic Inflammation and Interactions with the Microbiome)

Evaluates abstracts pertaining to basic visceral pain, microbiome, neuromediators, neurotransmitters, neurogenic Inflammation, pain, viscero-visceral cross talk, gut microbiota, visceral hypersensitivity.

The Microbiome-Gut-Brain Axis in Health and Disease

Functional cross-talk between the gut microbiota and the host nervous system (central and peripheral). Microbial neuroendocrinology in GI and extraintestinal disease. Microbial and biotic-based therapy: mechanisms of action and regulation of neuropathy, behavioral and autism spectrum disorders, functional bowel disease and abdominal pain, allergy, inflammatory and infectious disease. Nervous system control of microbiota composition and function.

Celiac Disease and Gluten Related Disorders

Aims to include studies on the immunology and cellular/tissue  pathogenesis of celiac disease and gluten sensitivity including  human, translational, basic in vitro cell and tissue models, genetic, and in vivo animal studies. Genetic studies which involve the elucidation of the mechanism or genetic factors that contribute to immunopathogenesis of celiac disease are included in this descriptor. Also included are large population studies that address genetics, prevalence of celiac disease in adults or children, comparative studies of risk, and differences in populations or secular trends.

Diet and the Gut Microbiome

Dietary impact on the composition and function of the gut microbiome and how their effects alter host-microbe interactions in conditions of health and disease. Microbial strains, mechanisms, mediators, and pathways that are involved in dietary effects on host and microbe. The role and actions of specific dietary components in affecting the gut microbiome. Clinical trials and studies of dietary intervention to reshape the gut microbiome as interventions for diseases and/or maintenance of health.

Endoscopic and Surgical Therapies of Obesity and Metabolic Disorders

Studies of the use of bariatric surgical techniques, such as sleeve gastrectomy, as well as new endoscopic non-surgical approaches, including balloons and other devices, and their associated techniques, indications, complications, effectiveness and post-procedure metabolic changes in the treatment of obesity and diabetes.

Epithelial Ion, Water and Nutrient Absorption

Aims to feature studies on biochemistry, biophysics, and cell biology of ion, salt, water and nutrient transporters of intestine.

Food Intolerances, Allergy, and Sensitivities

Disaccharide deficiencies, lactose, fructose or other food intolerances or sensitivities would be included and GI manifestations of food allergies. Studies that pertain to histamines or other responses to foods or dietary changes would also come under this descriptor.  The interaction between microbiome and diet, in particular, where it relates to disease or gastrointestinal function/dysfunction would also come under this descriptor.

Imaging and Therapeutic Intervention in Obesity and Metabolic Disease

Evaluates abstracts submitted to study the use of image modalities or applications of new or existing technology or therapeutic techniques for treatment of obesity or metabolic disorders such as diabetes.

Intestinal Failure/Short Gut: Basic and Clinical

Basic and clinical studies of intestinal failure, such as that due to short bowel syndrome and IBD, and therapeutic approaches to nutritional support, prevention of complications and facilitation of bowel adaptation and advancement of enteral nutrition.

Microbial Regulation of Host Metabolic and Energy Homeostasis

The role and mediators gut microbial regulation of host energy balance, digestion and absorption, circadian rhythm, and other metabolic targets and organs. Microbial role in obesity, metabolic syndrome, Type 2 diabetes, non-alcoholic liver disease, cardio-vascular complications, malabsorption, and malnutrition. Impact of these diseases on gut microbial function and composition.

Non-Alcoholic Fatty Liver Diseases and NASH

Research abstracts on all aspects of basic, translational, and clinical sciences related to non-alcoholic fatty liver disease and NASH.

Nutrient Absorption and Intestinal Epithelial Function

Basic and clinical studies of the digestion and intestinal absorption of nutrients (protein, carbohydrate and lipid), including studies of luminal factors, such as bile acids, as well as digestive enzymes, enterocyte transporters and other proteins involved in this process and their regulation.

Nutritional Support: Enteral and Parenteral

Studies of techniques, formulations and complications of the use of enteral and parenteral nutritional support for the treatment of GI diseases.

Obesity: Basic and Mechanistic Studies

Basic studies of the normal physiologic regulation of mechanisms contributing to body mass and metabolic state, as well as perturbations that occur in obesity and diabetes. Includes basic studies of mechanisms by which obesity and its metabolic complications are ameliorated by bariatric surgery and other therapeutic approaches.

Obesity: Clinical and Epidemiological Studies

Clinical and population-based studies addressing the pathophysiology and clinical features of human obesity and its complications, as well as mechanisms and effectiveness of therapeutic interventions.

Obesity: Pre-Clinical and Clinical

Pre-clinical and clinical studies of new therapeutic approaches to obesity and its complications, including nutritional and lifestyle interventions, bariatric surgical and non-surgical approaches, and pharmacotherapy.

Pediatric Nutrition and Obesity

Studies of the metabolic abnormalities and morbidities associated with obesity in children, including metabolic syndrome and NAFLD, and their relationship to nutrition and genetics. Also, studies of approaches to the treatment of pediatric obesity, including the roles of nutritional intervention, lifestyle changes, pharmacotherapy and bariatric surgery.

Regulation of Food Intake, Energy Expenditure and Metabolic Function

Basic and clinical studies of brain and gastrointestinal signaling networks that regulate caloric intake, energy expenditure and metabolic function and the perturbations that occur in disease states, including obesity and diabetes.

Vitamins and Micronutrients: Basic and Clinical

Basic and clinical studies of vitamins and micronutrients, including requirements and intestinal absorption in health and disease, transporter function and regulation, nutritional biology, metabolism and deficiency states.

Clinical Acute Pancreatitis

Considers epidemiology, etiology, severity prediction as well as medical, endoscopic and other minimally invasive management on outcomes. There is a separate basic science descriptor for basic science work in acute pancreatitis and not this one.

Clinical Chronic Pancreatitis

Considers clinical work in chronic pancreatitis including epidemiology, etiology, biomarkers, early and routine diagnosis, tests for exocrine insufficiency, enzyme replacement therapy, all treatments, type 3c diabetes clinical aspects.

Extraintestinal Interactions of the Gut Microbiome

Considers the functional cross-talk between the gut microbiota and extraintestinal organs (excluding nervous system). Microbiota-based mechanisms and therapy in extra-intestinal disease pathogenesis. Organs affected include: liver, pancreas, kidney, lymphoid, cardiovascular, bone, respiratory and mucosal systems.  Also, consider extraintestinal control of microbiota composition and function.

Molecular Mechanisms of Growth and Development of the GI Tract, Liver and Pancreas

Basic cellular mechanisms driving the establishment, development, and function of the digestive organs. Pathways driving cellular differentiation and organ maturation.

Pancreatic Cancer: Risk Factors, Biology, Diagnosis and Clinical Therapeutics

Both clinical and basic science aspects specially with biomarkers can fit in here. Almost all adenocarcinoma abstracts should fit this descriptor although there may be some overlap for cystic neoplasms and cancer with the descriptor PCN, IPMN and neuroendocrine tumors.

Pancreatic Cystic Neoplasms, IPMN and Neuroendocrine Tumors

This section is completely clinical for these 3 areas and any basic science work should be submitted to one of the 5 basic science descriptors. However, the imaging and endoscopy abstracts of these 3 diseases are encouraged to be submitted to the endoscopy and imaging descriptor.

Pancreatic Disorders: Endoscopy and Imaging

Endoscopic and radiological imaging abstracts on all clinical pancreatic diseases are best submitted here as this section is specially created to accommodate this kind of work. This being a recently introduced descriptor, the work has better chances of getting accepted in this descriptor location.

Pancreatic Genetics, Epigenetics, Physiology, Cell Biology and Pathobiology

Considers research in mechanisms of disease initiation and promotion.

Pancreatitis: Inflammation, Fibrogenesis and Immunology

This is an avenue for the basic work exclusively in both acute and chronic pancreatitis regardless of the type.

The Microbiome in Pancreatitis, Pancreatic Malabsorption and Pancreatic Tumorigenesis

Considers emerging work in microbiome in pancreatic diseases including effects of pancreatic diseases on the microbiome, as well as the effects of the microbiome on pancreatic diseases.

Watch Council Sessions from DDW 2017 with DDW On Demand

Thank you to everyone who attended Digestive Disease Week® (DDW) 2017 in Chicago. It was an extremely successful meeting thanks to your continued support. If you missed any sessions developed by the AGA Institute Council, you can watch them online with DDW On Demand (included in the cost of registration). If you were not able to attend DDW this year, but would like to view the sessions, you can purchase DDW On Demand.

Sections

Recommend

Recommend changes in abstract descriptor categories, or suggest topics and speakers.

Volunteer

Volunteer to review submitted abstracts or present your work at the next DDW.

 

 

How to Join a Section

The council is divided into 13 sections that represent special interest groups among AGA members. AGA invites all members to join up to six sections. By joining a section, AGA members will benefit from networking opportunities, professional recognition and growth, and involvement in the council’s educational programming at DDW and throughout the year. To join or manage your section affiliations, email agacouncil@gastro.org or visit My AGA. Review your section’s page for ideas on how you can get involved.

 
 

 

Meet the council
Maria T. Abreu, MD, AGAF
Council Chair: Maria T. Abreu, MD, AGAF

“I am honored and excited to have been chosen as the next AGA council chair. My goal will be to make the time spent by our AGA members at DDW the most impactful for their professions as clinicians and researchers. We will work as a group to reduce redundancy and make the program the most important single meeting members attend every year.”

 

Ronda Souza, MD, AGAF

Chair Elect: Ronda Souza, MD, AGAF

“ I LOVE DDW, and I am honored and excited to have been chosen as the next AGA Institute Council chair.  My goal is to create a DDW meeting that will invigorate and energize the minds of clinicians and scientists, both young and seasoned, reassuring them that their choice of a career in gastroenterology was the right one!  I will work with the AGA Institute Council members to create unique and non-redundant programming that will challenge unsubstantiated dogma, showcase cutting edge concepts and technologies, and highlight developments that impact clinical practice, making DDW the “must go to” professional meeting each year!

 

 

Interested in hearing more? Click here to watch a short video of Dr. Maria T. Abreu, chair of the AGA Institute Council, explaining what the council is, what it does, and how you can get involved!